Interpretation Of BBDRisk Dx® Test Results

The results of the BBDRisk Dx® test are reported to your ordering physician as a cancer risk score from 0-10 (a sample risk score and test report is shown in the diagram below). The higher the risk score, the higher one’s risk of developing breast cancer. In addition, it categorizes the patient as low risk, intermediate risk or high risk by comparing the patient’s risk score with the plurality of risk scores in Silbiotech’s data base. The test results report will also provide a cancer rate for a given risk score. Finally, the results report will also provide an overview of the clinical validation study.

In the example shown below the risk score is 4.1 and the patient is categorized as intermediate risk. Cancer rates for the risk score of 4.1 were 38% based on Silbiotech, Inc.’s validation study.

Treatment decisions can be made based on the cancer risk score and consultation between each patient and his or her healthcare professional (Figure below).

 

 

 

For example, standard screening for women whose BBDRisk Dx® results indicate a low risk score. If BBDRisk Dx® results indicate that a patient has an intermediate or high risk score, the following medical management options could be applied:

  • Increased surveillance
  • Risk-reducing medications and/or
  • Prophylactic surgery

The above may help reduce risk by 1) detecting it at an earlier more treatable stage, 2) delaying the onset of cancer, or 3) preventing the development of cancer over the long term

Disclaimer: Any discussion of medical management options provided here are for general informational purposes only and should not be interpreted as recommendations by Silbiotech, Inc. While BBDRisk Dx® test results provide useful information, medical management decisions should be made based on consultation between each patient and his or her healthcare professional. The patient and his or her doctor are solely responsible for making any medical management decisions.